These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 29370208)
1. Coronary magnetic resonance imaging after routine implantation of bioresorbable vascular scaffolds allows non-invasive evaluation of vascular patency. von Zur Mühlen C; Reiss S; Krafft AJ; Besch L; Menza M; Zehender M; Heidt T; Maier A; Pfannebecker T; Zirlik A; Reinöhl J; Stachon P; Hilgendorf I; Wolf D; Diehl P; Wengenmayer T; Ahrens I; Bode C; Bock M PLoS One; 2018; 13(1):e0191413. PubMed ID: 29370208 [TBL] [Abstract][Full Text] [Related]
2. Vasomotor Function Comparative Assessment at 1 and 2 Years Following Implantation of the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold and the Xience V Everolimus-Eluting Metallic Stent in Porcine Coronary Arteries: Insights From In Vivo Angiography, Ex Vivo Assessment, and Gene Analysis at the Stented/Scaffolded Segments and the Proximal and Distal Edges. Gogas BD; Benham JJ; Hsu S; Sheehy A; Lefer DJ; Goodchild TT; Polhemus DJ; Bouchi YH; Hung OY; Yoo SY; Joshi U; Giddens DP; Veneziani A; Quyyumi A; Rapoza R; King SB; Samady H JACC Cardiovasc Interv; 2016 Apr; 9(7):728-41. PubMed ID: 27056313 [TBL] [Abstract][Full Text] [Related]
3. Non-invasive imaging of bioresorbable coronary scaffolds using CT and MRI: First in vitro experience. Hickethier T; Kröger JR; Von Spiczak J; Baessler B; Pfister R; Maintz D; Bunck AC; Michels G Int J Cardiol; 2016 Mar; 206():101-6. PubMed ID: 26785034 [TBL] [Abstract][Full Text] [Related]
4. Bioresorbable vascular scaffolds for small vessels coronary disease: The BVS-save registry. Latini RA; Granata F; Ielasi A; Varricchio A; Moscarella E; Tespili M; Cortese B Catheter Cardiovasc Interv; 2016 Sep; 88(3):380-7. PubMed ID: 27038332 [TBL] [Abstract][Full Text] [Related]
5. Bioresorbable vascular scaffold thrombosis in a consecutive cohort of 550 patients. Tröbs M; Achenbach S; Röther J; Klinghammer L; Schlundt C Catheter Cardiovasc Interv; 2016 Nov; 88(6):872-880. PubMed ID: 27142643 [TBL] [Abstract][Full Text] [Related]
6. Follow-up of coronary artery patency after implantation of bioresorbable coronary scaffolds: The emerging role of magnetic coronary artery imaging. Zuin M; Rigatelli G; Scaranello F; Rinuncini M; Picariello C; D'Elia K; Fejzo M; Roncon L Cardiovasc Revasc Med; 2017; 18(5):369-373. PubMed ID: 28254259 [TBL] [Abstract][Full Text] [Related]
7. Mid- to long-term outcome of patients treated with everolimus-eluting bioresorbable vascular scaffolds: Data of the BVS registry Göttingen predominantly from ACS patients. Hellenkamp K; Becker A; Gabriel YD; Hasenfuß G; Hünlich M; Jacobshagen C; Schillinger W; Schroeter MR Int J Cardiol; 2017 May; 234():58-63. PubMed ID: 28258843 [TBL] [Abstract][Full Text] [Related]
8. Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data. Bourantas CV; Serruys PW; Nakatani S; Zhang YJ; Farooq V; Diletti R; Ligthart J; Sheehy A; van Geuns RJ; McClean D; Chevalier B; Windecker S; Koolen J; Ormiston J; Whitbourn R; Rapoza R; Veldhof S; Onuma Y; Garcia-Garcia HM EuroIntervention; 2015 Nov; 11(7):746-56. PubMed ID: 25308301 [TBL] [Abstract][Full Text] [Related]
9. One-Year Clinical and Computed Tomography Angiographic Outcomes After Bioresorbable Vascular Scaffold Implantation During Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: The PRAGUE-19 Study. Widimsky P; Petr R; Tousek P; Maly M; Linkova H; Vrana J; Hajsl M; Budesinsky T; Lisa L; Kocka V Circ Cardiovasc Interv; 2015 Dec; 8(12):e002933. PubMed ID: 26628591 [TBL] [Abstract][Full Text] [Related]
10. A 12-month angiographic and optical coherence tomography follow-up after bioresorbable vascular scaffold implantation in patients with ST-segment elevation myocardial infarction. Kochman J; Tomaniak M; Kołtowski Ł; Jąkała J; Proniewska K; Legutko J; Roleder T; Pietrasik A; Rdzanek A; Kochman W; Brugaletta S; Kaluza GL Catheter Cardiovasc Interv; 2015 Oct; 86(4):E180-9. PubMed ID: 26015294 [TBL] [Abstract][Full Text] [Related]
11. ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design. Diletti R; Serruys PW; Farooq V; Sudhir K; Dorange C; Miquel-Hebert K; Veldhof S; Rapoza R; Onuma Y; Garcia-Garcia HM; Chevalier B Am Heart J; 2012 Nov; 164(5):654-63. PubMed ID: 23137495 [TBL] [Abstract][Full Text] [Related]
12. Procedural and one-year clinical outcomes of bioresorbable vascular scaffolds for the treatment of chronic total occlusions: a single-centre experience. Özel E; Taştan A; Öztürk A; Özcan EE; Kilicaslan B; Özdogan Ö Cardiovasc J Afr; 2016 Nov/Dec 23; 27(6):345-349. PubMed ID: 27078224 [TBL] [Abstract][Full Text] [Related]